Vyas Tungaturti is an M&A advisor with nearly two decades on the execution side of deals: first at Deloitte Consulting, then, since 2018, as an independent advisor to Big 4 firms on due diligence, integration and carve-outs across more than 50 transactions. He founded CorpDev.Org, runs CogTech, and builds Kai, AI-native due diligence for M&A and PE teams: upload a data room and within hours Kai has read every document, found every risk and opportunity, priced with evidence, and traced every figure to its source.
Private equity firm Thoma Bravo is preparing to capitalize on the booming document processing software market through a potential $3 billion-plus sale of Apryse, according to multiple financial and...
The telehealth sector witnessed a transformative move on June 3, 2025, as Hims & Hers Health (NYSE: HIMS) announced its acquisition of ZAVA, a leading European digital health platform. This $1.2...
As Merck & Co. confronts the impending 2028 patent expiration of its $29.5 billion oncology blockbuster Keytruda, the pharmaceutical giant's reported $3 billion pursuit of MoonLake...
The U.S. Department of Justice's intervention in Keysight Technologies' $1.5 billion acquisition of Spirent Communications underscores a paradigm shift in antitrust enforcement for technology...
In a landmark move signaling deeper convergence between optical manufacturing and clinical care, EssilorLuxottica announced its acquisition of Optegra Eye Health Care from private equity firm...
The energy sector witnessed its most significant minerals and royalties consolidation in three years as Viper Energy (NASDAQ:VNOM), a Diamondback Energy (NASDAQ:FANG) subsidiary, announced its $4.1...
McKesson Corporation solidified its position in community oncology with the June 2025 completion of its $2.49 billion acquisition of 70% controlling interest in Core Ventures, the administrative arm...
The collapse of KKR's £4 billion rescue bid for Thames Water marks a pivotal juncture in Britain's infrastructure landscape. As bond prices plunge to record lows and regulators impose unprecedented...
In a landmark transaction finalized on May 30, 2025, National Grid plc (LSE: NG) completed the $1.735 billion sale of its U.S. onshore renewables subsidiary to Brookfield Asset Management and...
Bruker Corporation's $BRKR acquisition of Austrian metabolomics leader Biocrates Life Sciences AG marks a pivotal expansion in the $12.7 billion multiomics sector . This undisclosed-value...
